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Objectives: This study aims to determine if patients with acute myocardial infarction differ in illness
perception and secondary prevention outcomes depending on the treatment they received.
Methods: A repeated measures design was used to compare patients with acute myocardial infarction
receiving three different treatment modalities: ST-elevation myocardial infarction treated by primary
percutaneous coronary intervention, ST-elevation myocardial infarction treated by thrombolytic therapy,
and non ST-elevation myocardial infarction treated by medication. A convenient sampling technique was
used to recruit 206 patients with acute myocardial infarction who agreed to participate in the current
study. Patients' illness perception, physical activity, and demographical and clinical data were collected
during hospital admission and again at 6 months.
Results: A total of 186 patients completed the study. Results showed that the primary percutaneous
coronary intervention group perceived their illness as acute rather than chronic (P ¼ 0.034) and has
lower personal control (P ¼ 0.032), higher treatment control (P ¼ 0.025), and higher perception of illness
coherence (P ¼ 0.022) compared with patients receiving thrombolytic therapy and treated after non-ST
segment infarction. Moreover, they report low control of their blood pressure (P ¼ 0.013) and less
physical activity (P ¼ 0.001).
Conclusion: The results of this study revealed that patients' treated with primary percutaneous coronary
intervention had negative illness perception and limited behavioral changes 6 months after hospitali-
zation in comparison with other treatment modalities such as percutaneous coronary intervention and
thrombolytic treatment. Further research is recommended to conﬁrm this association with longer
follow-up study and among different cultures.
© 2017 Chinese Nursing Association. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction and background
Coronary artery disease (CAD) was the primary cause of death,
accounting for approximately 37% of cardiovascular deaths and 15%
of total deaths in Jordan in 2012 http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [1]. Myocardial infarction
(MI) is the leading cause of death globally and is aworldwide health
problem http://www.sciencedirect.com/science/article/pii/S2352
013216301879 [2]. Both primary and secondary prevention of MI
are major priorities. Diagnosis of acute myocardial infarction (AMI)
is based on the type of electrocardiography changes, which are of
two types: ST-segment elevation MI (STEMI) and non-ST-segment
elevation MI (NSTEMI) http://www.sciencedirect.com/science/
article/pii/S2352013216301879 [2].
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The management of patients with STEMI includes either
sending them directly to the cardiac catheterization laboratory to
re-open the occluded vessels using a procedure called primary
percutaneous coronary intervention (PPCI) or emergency admin-
istration of ﬁbrinolysis if the facility of PPCI is not available. Indeed,
PPCI is considered a superior treatment for patients with STEMI
when it is available within the necessary time period http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [3], and
patients may be discharged within 48 h, leaving little time for
secondary prevention to be established.
Patients with AMI who presented with NSTEMI are treated
initially by medication rather than with a ﬁbrinolytic agent. For
both NSTEMI and patients with AMI treated with ﬁbrinolytic, they
frequently require coronary angiography before hospital discharge
with possible percutaneous coronary intervention (PCI) by opening
the occluded vessel through stent or percutaneous transluminal
coronary angioplasty by opening the occluded vessel through
balloon http://www.sciencedirect.com/science/article/pii/S2352
013216301879 [4]. As a result, each one of the three AMI treat-
ment modalities is exposed to different experiences during hospi-
talization in terms of treatment urgency and length of stay.
Literature claims that this may inﬂuence patients' understanding of
their diagnosis http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [5] and motivation for secondary prevention,
and this study seeks to address this gap.
All patients with either STEMI or NSTEMI will be told that they
have had a heart attack and, where appropriate, are advised to
make behavioral changes http://www.sciencedirect.com/science/
article/pii/S2352013216301879 [6]. However, given the very
different experiences in terms of urgency of treatment initiation
and hospital stay length, it is understandable that it can be difﬁcult
for all patients with an AMI diagnosis to understand this fully
http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [5]. Research has shown that some patients
who had PPCI perceived a mismatch between their expectations of
treatment and recuperation and their actual experience, which led
them to question the seriousness of their illness, and to consider it
as acute rather than as a chronic condition http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [5].
Such perceptions may make it more difﬁcult for patients to un-
derstand the chronicity of their illness and undertake the lifestyle
changes necessary to prevent further disease progression http://
www.sciencedirect.com/science/article/pii/S2352013216301879
[7]. Less evidence is found in terms of patients' understanding of an
NSTEMI diagnosis, but qualitative data would suggest that their
experience of a protracted and sometimes ambiguous diagnosis
may also cause patients to question the seriousness of the event
and the need for behavioral change http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [8].
Illness perception (IP) is the organized cognitive representation
or views that patients develop to make sense of their illness
experience http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [9]. The Self-Regulation Model (SRM) of Lev-
enthal et al. (1984) provides a theoretical explanation of the
concept of IP and the factors that inﬂuence individual's coping
behavior and outcomes. The model postulates that when an indi-
vidual is facing a health problem, he or she will be motivated to
regulate the health-related risk consistent with his or her percep-
tion of an illness. According to the SRM, outcomes of behavioral
changes are a reﬂection of patients' coping strategies that, in turn,
are affected by their illness beliefs.
Secondary prevention is the second level of heath care that in-
cludes measures to control and limit the negative impact of an
illness. Among patients diagnosed with MI, secondary prevention
measures are highly recommended to avoid further disease
progression and complications. These measures mainly include
physical activity, smoking cessation, blood pressure and lipid
management, and weight control http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [10].
The IP of patients with AMI has been considered a predictor of
their functional status, returning to work, depressive symptoms,
and attendance at cardiac rehabilitation clinics http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [11].
Although IPs are an important determinant of individual behavioral
changes in CAD http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [12], sparse evidence is found regarding the
implication of the fast track services of PPCI on patients' psycho-
logical and health behavior changes, and little is known about AMI
patients' experiences and perceptions during and after PPCI http://
www.sciencedirect.com/science/article/pii/S2352013216301879
[13]. To our knowledge, this is the ﬁrst study to compare IP and
associated outcomes among patients with AMI receiving different
treatment modalities. This study aims to evaluate if treatment
modality inﬂuences IP and the outcomes of behavioral change
(obesity, smoking status, blood lipids, physical activity, and blood
pressure) among patients with AMI. Hence, the present study aims
to answer the following question: Do patients with AMI differ in IP
and secondary prevention outcomes (SPO) depending on the
treatment they received?
2. Methods
2.1. Design
A quantitative repeated-measure design was used to assess the
inﬂuence of the three selected treatment modalities on IP and the
outcomes of behavioral change among patients with AMI. This
design was appropriate to collect and examine changes in study
measures during patients' hospitalization and after 6 months.
2.2. Sample and setting
This study was conducted in the International Heart Institute in
Amman. As the largest heart institute in Jordan and having patients
admitted from across Jordan, we choose this institute and assume
that the Jordanian populationwill be fairly represented. In addition,
this institute is a specialized heart institute with a total of 170-bed
capacity and performs cardiac surgery in addition to more than
12,000 cardiac catheterization procedures annually, including PPCI.
This heart institute provides care for patients from Jordan, the re-
gion, and worldwide.
A convenience sampling technique was used to recruit the
participants in the current study. The inclusion criteria were as
follows: ﬁrst-time AMI, over 18 years of age, physically and
mentally competent, pain free and hemodynamically stable in
which they have stable vital signs for more than 8 h, and agreed to
participate in the study. The exclusion criteria were as follows:
patients had previous MI and refused to participate in the study.
The power analysis calculation indicated that a sample of 186
patients was required, with conﬁdence interval of 5%, 95% conﬁ-
dence level, and estimated number of 365 patients admitted
annually to the hospital presented with ﬁrst-time AMI. To account
for attrition in the follow-up time, 10% was added to the calculated
sample size; consequently, 206 patients were recruited to meet the
target sample of 186 patients.
2.3. Data collection procedure
Approval for the study was sought and obtained from one of the
Universities in the United Kingdom and from the hospital research
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ethics board in Jordan. The primary researcher provided verbal and
written explanations about the study. All participants' ﬁles were
reviewed by the primary researcher to insure the eligibility of the
participants to participate in the study. After that, the written
informed consent was obtained from each participant. Then,
baseline data were collected using the revised IP questionnaire and
the short form of physical activity questionnaire. All patients were
interviewed after they were transferred from the Intensive Cardiac
Care Unit to the General Care Unit. All participants were pain free
and have had stable vital signs.
The follow-up data collection took place at 6 months via a
telephone interview. Patients' hospital medical records were
reviewed again at this stage, which was 6 months following hos-
pitalization. Different measures were applied to minimize potential
bias; these measures include the following: data were collected
from one trained researcher, standardized information was pro-
vided to all study participants, and all possible patients who were
admitted to the hospital were screened for their eligibility. The time
spent for each patient to complete the baseline interview ranged
from 15 min to 20 min, and for the follow-up telephone interview,
time spent ranged from 12 min to 15 min. The data were collected
by the primary investigator for this research study.
2.4. Instrumentation
Questionnaire fo data collection consisted of three parts:
demographical and clinical data, the Revised Illness Perception
Questionnaire (IPQ-R), and the International Physical Activity
Questionnaire (IPAQ). The medical records were examined at both
the baseline and follow-up data time points to gather the required
data on lipid proﬁle results, blood pressure, height and weight,
coronary angiography result, and hospital length of stay. The out-
comes of secondary prevention were operationally deﬁned in this
study by BMI, lipid proﬁles, blood pressure, smoking behavior, and
physical activity.
The second part of the questionnaire is the Revised Illness
Perception Questionnaire (IPQ-R): the IPQ-R was developed by
http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [14]. The IPQ-R sub-scales used in this study
were “Timeline Acute/Chronic” (six items); “Timeline Cyclical”
(four items); “Consequences” (six items); “Personal Control” (six
items); “Treatment Control” (ﬁve items); “Illness Coherence” (ﬁve
items), and “Emotional Representation” (six items). It contains 38
items, whichweremeasured on a Likert scale ranging from strongly
disagree (1) to strongly agree (5). Higher score of each sub-scale
indicates higher perception of chronicity, cycle nature, conse-
quences, personal control, treatment control, perception of their
understanding, and emotions related to patient's illness.
Translation and backtranslation were performed and the pro-
cess involved two teams of translators. The ﬁrst team consisted of
two nurses, both of whom held a master's degree in nursing and
had clinical experience; they were also asked to independently
translate the source. The two translators and the researcher then
synthesized the translations to produce one version of translation.
The second team consisted of two people, both of whom hold a
master's degree in English language; they were also asked to
independently translate back into English the translated Arabic
version.
Following the back translation of the Arabic version, the trans-
lators and the researcher met as a committee to review all the
translations and to compare the original version and back trans-
lation versions. As a result, a consensus was made within the team
as to the appropriateness of the translation. The appropriateness of
the ﬁnal Arabic translated version of the instruments was tested
during the pilot study: 15 participants were asked to comment on
the clarity of the questions, and these participants were not
included in the ﬁnal sample. Patients reported that the question-
naire instruction, questions, and choices were clear. In addition,
pilot testing indicated that no problems were encountered during
the process of data collection, coding, and analysis. The IPQ-R has
beenwidely used with different clinical populations with adequate
reliability (Cronbach's a ranged from 0.79 to 0.89) and internal
validity http://www.sciencedirect.com/science/article/pii/S23520
13216301879 [14].
A conﬁrmatory factor analysis was conducted to examine the
ﬁtting participants' responses to the IPQ-Rwith the latent construct
of the questionnaire and examine the reliability of the question-
naire. The data collected at baseline were used to test the factor
structure of IPQ-R using theMPLUS statistical package (version 6.1).
Established criteria of ﬁt statistics [Chi-square, root mean square
estimate of approximate (RMSEA), and CFI] were used to examine
the appropriateness of the measurement model in explaining the
data.
Recommendation of the standardized RMSEA was used to
indicate the overall ﬁt between the speciﬁc model and the data set
with 0.08 or below, and CFI with 0.90 or greater. If the original
model measurement model was deemed not to ﬁt the data, the
following criteria of modiﬁcation were introduced: items with
factor loading less than 0.4 were removed. This process continued
to an acceptable model and was identiﬁed to have acceptable factor
loading scores. The original IPQ-R seven-structure model was
tested following the ﬁt process and was deemed to ﬁt to data. As a
result, the ﬁnal model ﬁt with the data, and 32 items represented
the original seven construct of IPQ-R with RMSEA at 0.074 and CFI
at 0.97.
The third part of the questionnaire is the Short Form of the IPAQ.
To assess the patients' activity, the short form IPAQ-7-days-recall
telephone interview version was used http://www.sciencedirect.
com/science/article/pii/S2352013216301879 [15]. Following IPAQ
scoring protocol, patients were categorized into three different
activity levels: low, moderate, and high physical activity. The val-
idity and reliability of the IPAQ were tested in 12 countries and
showed that the short form of IPAQ has acceptable validity and
reliability, with criterion validity of a median of 0.3 http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [15].
2.5. Ethical consideration
The ethical issues were considered carefully, given the clinical
condition of the patient group. Approval for the study was sought
and obtained. The ethical approval number was 10/2015. Written
informed consent was obtained from all the participants who
agreed to participate in the study. Conﬁdentiality of participants
was assured by offering a code number for each participant at the
point of data collection and analysis. Participation was completely
voluntary, and participants had the right to withdraw from the
study at any time. No physical or psychological harm affected the
participants because the data collection relied on noninvasive
questionnaire.
2.6. Data analysis
Descriptive, inferential, and multivariate statistical methods
were used to analyze the data. Descriptive statistics were used to
describe the sample characteristics. Conﬁrmatory factor analysis
was used to test data ﬁtting to the scale factors. At baseline, Chi-
square, Fisher's exact test, and ANOVA were used to examine the
differences between the selected treatment modalities and the
study measures. Changes between the groups' baseline and follow-
up time's outcome measures were analyzed using Mcnemar's test,
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Wilcoxon, and repeated ANOVA. No data were missed as the
researcher reviews each question after patients ﬁlled the form and
encourages them to ﬁll it without keeping any missing data.
3. Results
At baseline time point (i.e., during hospitalization), 263 patients
were assessed for eligibility. However, 36 patients were not eligible
(i.e., 29 were not ﬁrst-time AMI and 7 were not medically stable to
be part of the study) and 21 refused to participate in the study. As a
result, 206 patients participated in the baseline data point. Six
months later, 186 patients completed the questionnaire pack (i.e.,
11 patients died, 5 were not reachable, and 4 refused to complete
the follow-up data). Two-hundred and six participants completed
the questionnaire at the baseline, and 186 completed the study at
follow-up.
More than two-thirds of the participants were aged between 51
and 80 years old (n ¼ 131, 70%). A total of 79% of the samples were
male (n ¼ 147), and 84% of the sample were married. Approxi-
mately half of the samples were employed and have a bachelor's
degree or higher. Differences were examined between the three
selected treatment modalities using Chi-square and Fisher exact
test; results show no signiﬁcant difference in personal demo-
graphical details, as shown in Tables 1 and 2.
Table 2 shows the examined differences between the three
selected treatment modalities using Chi-square and Fisher exact
test; results show signiﬁcant differences in all of the clinical
demographical details except the previous history of illness. Pa-
tients treatedwith thrombolytic therapy (THROMB) had higher rate
of PCI in comparison with NSTEMI patients. In addition, results
show signiﬁcant differences in hospital length of stay c2
(1) ¼ 35.50, P ¼ 0.001; PPCI patients had shorter length of stay and
stayed for 48 h or less as in comparisonwith THROMB patients and
NSTEMI patients.
One-way ANOVA was performed to examine the differences in
IP based on treatment modality. The results indicated that no sig-
niﬁcant difference exists across the treatment modalities in IP at
baseline, as shown in Table 3. To examine the differences in change
between the three treatment modalities, a repeated measure of
ANOVA was performed. The results indicated that signiﬁcant
changes exist between the baseline and follow-up times in four of
seven IP factors, i.e., timeline acute/chronic, personal control,
treatment control, illness coherence.
Signiﬁcant difference exist in timeline acute/chronic based on
patients treatment modalities (F ¼ 3.43, P ¼ 0.034). Post hoc test
showed that PPCI patients had signiﬁcant higher perception of
acuteness of their illness in comparison with both THROMB and
NSTMI patients. No signiﬁcant difference exists between THROMB
and NSTEMI groups. In addition, signiﬁcant difference is observed
in mean scores of personal control (F ¼ 8.43, P ¼ 0.032). Post hoc
test showed that PPCI patients had signiﬁcant lower mean score for
perception of personal control over their illness in comparisonwith
THROMB patients. No signiﬁcant difference is observed between
PPCI and NSTMI and between THROMB and NSTEMI groups.
Perception of treatment control signiﬁcantly differed based on
patient's group (F¼ 3.75, P¼ 0.025). Post hoc test showed that PPCI
patients had signiﬁcant higher perception of treatment control over
their illness in comparison with both THROMB and NSTMI groups.
No signiﬁcant difference was observed between THROMB and
NSTEMI groups. Moreover, perception of illness coherence signiﬁ-
cantly differed based on patient's group(F ¼ 4.90, P ¼ 0.022). Post
hoc test showed that PPCI patients had signiﬁcant higher mean
score for perception of illness coherence in comparison with
NSTEMI group. No signiﬁcant difference is observed between PPCI
and THROMB and between THROMB and NSTEMI.
In the differences across the treatment modalities for behavioral
measures in the baseline time, Chi-square results indicated no
signiﬁcant difference based on treatment modalities, as shown in
Tables 4 and 5. In addition, the changes between the baseline and
follow-up time in terms of SPO, Mcnemar's test, and Wilcoxon test
were used and results show no signiﬁcant change in BMI and LDL.
However, signiﬁcant changes exist between the baseline and
follow-up times in cholesterol (i.e., THROMB group had signiﬁcant
higher control of cholesterol), BP (i.e., PPCI had signiﬁcant lower
control of BP), activity level (i.e., THROMB had signiﬁcant higher
activity level), and smoking (i.e., each group showed lower
smoking).
4. Discussion
This study aimed to examine the differences in IP and associated
behavioral outcomes among patients with AMI receiving different
treatment modalities. The current study showed that PPCI group
perceived their illness as acute rather than chronic 6 months after
hospitalization in comparison with other treatment modalities.
Previous study showed that the patients' perception of their illness
Table 1
Sample characteristics: number, percent (%), and P value to examine the signiﬁcant difference for the three selected treatment modalities.
Categories Total No. (%) PPCI No. (%) THROMB No. (%) NSTEMI No. (%) c2 P
Age
18e30 2 (1.1) 1 (1.5) 0 1 (1.7) 1.90 0.06
31e40 10 (5.4) 2 (3.1) 7 (10.8) 1 (1.7)
41e50 36 (19.4) 13 (21.0) 16 (25.8) 7 (11.9)
51e80 131 (70.4) 45 (69.2) 38 (61.3) 48 (81.4)
81e100 7 (3.8) 4 (6.2) 1 (1.6) 2 (3.4)
Gender
Female 39 (21.0) 16 (24.6) 11 (17.7) 12 (20.3) 0.51 0.63
Male 147 (79.0) 49 (75.4) 51 (82.3) 47 (79.7)
Marital status
Single 21 (11.3) 9 (13.8) 3 (4.8) 9 (13.9) 1.20 0.08
Married 158 (84.9) 51 (78.5) 59 (95.2) 48 (81.4)
Divorced or widowed 7 (3.8) 5 (7.7) 0 2 (3.4)
Education level
Secondary school or lower level 90 (48.4) 30 (45.9) 31 (50.0) 29 (49.2) 0.73 0.93
Or higher 96 (51.6) 35 (53.9) 31 (50.0) 30 (50.8)
Employment
Working 90 (48.4) 26 (40.0) 36 (58.1) 28 (47.5) 0.92 0.12
Not working 96 (51.6) 39 (60.0) 26 (42.0) 31 (52.5)
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trajectory as acute or chronic affects their motivation for behavioral
changes, including taking secondary prevention measures. Evi-
dence has suggested that patients with CAD who perceive their
illness as chronic were more conﬁdent in making changes to their
behavior in comparison with those who perceived their illness as
being acute http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [12]. Such perception of chronicity of illness
may limit behavioral changes shown in this study as blood lipids
and physical activity.
Moreover, result indicates that PPCI group had lower personal
control and higher treatment control over their illness in compar-
ison with the THROMB and NSTEMI groups. Previous studies
showed inconsistent ﬁndings with regard to the effect of percep-
tion of control over the illness has an effect on patients' behavioral
changes. A greater perception of higher control over the illness
among patients with AMI has led them to be highly motivated to
change their behavior http://www.sciencedirect.com/science/
article/pii/S2352013216301879 [16]. However, another study re-
ported that patients who felt that they had a high degree of control
over their illness were less likely to showmotivation for behavioral
changes http://www.sciencedirect.com/science/article/pii/S23520
13216301879 [17]. Indeed, these studies measure control as one
factor rather than two distinct factors: personal and treatment
control, which were measured in the current study that may affect
the generalizability of their results. Lower perception of personal
control and higher treatment control over PPCI group may limit
their behavioral changes, as shown in the current study.
Patients who had PPCI in the current study were found to have
higher perception of illness coherence; this refers to their percep-
tion of understanding their illness 6 months after hospitalization.
An earlier study found that patients with AMI who had a good
understanding of their illness were more likely to change their
health-related behavior http://www.sciencedirect.com/science/
article/pii/S2352013216301879 [18]. In this study, the PPCI group
did not report higher motivation or behavioral changes after the
illness compared with those from other treatment modalities. This
might be due to the fact that patients who had PPCI report fewer
symptoms than patients in other groups; while they may believe
that they understand their illness, in actuality they do not.
The majority of the patients in this study had one or more pre-
vious illnesses, including CAD risk factors. This result is consistent
with previous studies conducted in Jordan http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [19]. Pa-
tients in the current study have higher rates of smoking and lower
HTN and dyslipidemia in comparison with patients in other coun-
tries, such as those in Europe http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [20]. The primary and sec-
ondary prevention strategies to prevent development and recur-
rence of the cardiac diseases in Jordan are limited http://www.
sciencedirect.com/science/article/pii/S2352013216301879 [21], and
this might explain the higher rates of smoking among the current
study patients. With the presence of higher risk factors among pa-
tients with AMI, as shown in this study, greater effort is needed to
minimize this risk by providing secondary prevention strategies.
Table 2
Patients' clinical demographics and P value to examine the signiﬁcant difference between the three selected treatment modalities.
Categories Total No. PPCI THROMB NSTEMI c2 P
Coronary angiography result 3.21 0.001
PPCI 65 65 0 0
PCI 85 0 48 37
Treated by medications only 31 0 11 20
PTCA 3 0 2 1
Normal Coronary 1 0 1 0
No Angiography done 1 0 0 1
Length of Stay 3.55 0.001
48 h or less 12 12 0 0
49e72 h 64 41 8 15
73e96 h 89 11 43 35
97 h or more 21 1 11 9
History of illness 1.11 0.220
No history 55 15 23 17
History of illness 131 50 39 42
Table 3
Illness perception factor result for the baseline and follow-up time(Mean ± SD).
IPQ-R factors (Illness perception) Overall PPCI THROMB NSTEMI ANOVA (Baseline) Repeated ANOVA
F P F P
Timeline Acute/chronic Baseline 3.0 ± 0.9 3.0 ± 0.8 3.0 ± 0.8 3.1 ± 0.9 0.68 0.957 3.43 0.034
Follow-up 3.1 ± 0.8 2.7 ± 1.0 3.4 ± 0.9 3.3 ± 0.8
Timeline cyclical Baseline 2.8 ± 0.9 2.7 ± 1.0 2.7 ± 0.9 2.9 ± 0.8 0.91 0.370 1.12 0.084
Follow-up 2.5 ± 1.1 2.2 ± 1.1 2.7 ± 0.9 2.7 ± 0.9
Consequences Baseline 3.3 ± 0.9 3.2 ± 0.9 3.2 ± 1.1 3.4 ± 1.0 0.88 0.588 0.98 0.150
Follow-up 3.1 ± 0.8 2.8 ± 0.8 3.6 ± 1.0 3.2 ± 0.8
Personal control Baseline 3.0 ± 0.9 3.1 ± 1.0 3.0 ± 0.9 3.0 ± 1.0 0.98 0.557 8.43 0.032
Follow-up 3.0 ± 1.0 2.6 ± 0.8 3.2 ± 1.1 3.1 ± 0.9
Treatment control Baseline 3.7 ± 0.8 3.7 ± 0.9 3.7 ± 1.0 3.7 ± 1.1 0.81 0.863 3.75 0.025
Follow-up 4.0 ± 1.1 4.3 ± 0.9 3.8 ± 0.9 3.8 ± 0.8
Illness coherence Baseline 4.1 ± 0.9 4.0 ± 0.8 4.2 ± 0.8 4.2 ± 0.9 0.98 0.339 4.90 0.022
Follow-up 4.2 ± 1.0 4.3 ± 1.1 4.2 ± 0.9 4.0 ± 1.0
Emotional representation Baseline 2.6 ± 0.9 2.5 ± 1.0 2.5 ± 0.8 2.6 ± 1.1 0.63 0.808 1.34 0.074
Follow-up 2.2 ± 0.8 2.0 ± 0.9 2.4 ± 0.8 2.3 ± 0.9
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The outcomes of behavioral changes between the baseline and
follow-up time among the patients with AMI were limited except
for smoking status. Previous studies on secondary prevention
among AMI patients, though limited, were consistent with this
result. A previous study conducted in Jordan found that 29.7% of
patients with CAD stopped smoking after the illness, and the main
motivator was physicians' advice http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [22]. Previous studies have
shown the effectiveness of cardiac rehabilitation programs (CRP) in
increasing behavioral changes after cardiac events and in
improving patients' outcomes http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [23]. Unfortunately, Jordan
lacks CRP, and this might limit the behavioral changes of patients
with AMI in the current study.
The clinical demographical details showed some differences
between the three treatment modalities. Previous studies show
that patients who had PPCI had a shorter length of hospital stay
http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [13]. The PPCI group's hospital stay is short
length, which may limit the ability of patients who had PPCI to
recall the information given by health care team during hospitali-
zation http://www.sciencedirect.com/science/article/pii/S235201
3216301879 [24]. This may increase the importance of follow-up
visits with these patients to ensure that they understand the in-
formation that is given to them and to ensure the appropriate
understanding of the nature of their illness and behavioral changes.
The ﬁndings of this study should be received cautiously, given
that it has a number of limitations. First, the studywas conducted in
Jordan where formal CRP is not found; other countries where pa-
tients with AMI have access to CRP might have greater under-
standing of the nature of their illness and the ways to change their
behavior. Second, a longer follow-up time might have revealed
further changes in patients' IP and behavior. A previous study
showed that patients with AMI had increased their coping and
experience of illness over time http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [25]. Third, the convenient
sample and the study being conducted in one cardiac center will
limit the generalizability of the study ﬁndings among Jordanian
population.
5. Implication for practice
Previous studies have shown the importance of CRP after AMI
http://www.sciencedirect.com/science/article/pii/
S2352013216301879 [23]. Patients with AMI in Jordan do not have
access to CRP. Cardiac rehabilitation has increased patients'
knowledge about the nature of their illness and increase their
motivation for behavioral changes http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [21]. The study ﬁndings
showed the importance of assessing patients' understanding or IP
after AMI, particularly patients treated with PPCI to insure appro-
priate understanding of their illness and to increase their
Table 4
Outcomes of secondary prevention in baseline and follow-up time (n).
Factors Total No. PPCI THROMB NSTEMI Baseline Mcnemar's test
c2 P Z P
BMI 0.86 0.474 1.34 0.219
Controlled Baseline 63 19 24 20
Follow-up 67 20 27 20
Not controlled Baseline 114 44 35 35
Follow-up 110 43 32 35
LDL 1.23 0.087 1.45 0.064
Controlled Baseline 47 12 19 16
Follow-up 56 15 24 17
Not controlled Baseline 83 36 21 26
Follow-up 74 33 16 25
Cholesterol 0.76 0.249 2.45
(THROMB group)
0.02
Controlled Baseline 39 11 16 12
Follow-up 58 17 24 17
Not controlled Baseline 96 38 26 32
Follow-up 77 32 18 27
BP 0.78 0.368 3.56
(PPCI group)
0.013
Controlled Baseline 146 55 48 43
Follow-up 145 45 53 47
Not controlled Baseline 29 7 11 11
Follow-up 30 17 6 7
Smoking 0.77 0.626 3.46 0.001
Non smoker Baseline 77 27 23 27
Follow-up 109 36 38 35
Smoker Baseline 109 38 39 32
Follow-up 77 29 24 24
Table 5
Physical activity results for both baseline and follow-up time.
Activity Level Categories Baseline Follow-up
Total No. PPCI THROMB NSTEMI Total No. PPCI THROMB NSTEMI
Low 138 46 49 43 124 50 33 41
Moderate 40 18 9 13 49 14 22 13
High 8 1 4 3 13 1 7 5
Note: Chi-square for baseline, P ¼ 0.45; Wilcoxon test for the change, P ¼ 0.001.
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motivation for behavioral changes http://www.sciencedirect.com/
science/article/pii/S2352013216301879 [18,26]. Health care pro-
viders, such as nurses, play an important role in assessing patients'
IP, initially during hospitalization and later at the follow-up
outpatient clinic.
6. Conclusion and recommendations
The results of this study revealed that patients treated with PPCI
had negative IP, such as perception of acuteness of their illness,
lower personal control, and limited behavioral changes 6 months
after hospitalization in comparison with other treatment modal-
ities. These differences showed in the current study, particularly
among the PPCI group, should be taken in consideration, as it may
impact on their behavioral changes. Educators, including nurses,
have a signiﬁcant role in assessing and educating PPCI to ensure
appropriate understanding of their illness. Further research is
recommended to explore the differences in IP and behavioral
changes among different AMI groups with longer follow-up. A
larger, heterogeneous randomized selected sample of patients with
AMI can be used in future studies to improve generalizability of the
study ﬁndings among Jordanian population. Furthermore, the au-
thors of this study highly recommend further qualitative study that
aims to explore IPs and the associated SPO among patients diag-
nosed with MI.
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